Ayala Pharmaceuticals Inc (OP: ADXS )

0.0270 UNCHANGED
Streaming Delayed Price Updated: 3:23 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
April 01, 2010
Form 424B3
Source: SEC/Edgar
April 01, 2010
Form 424B3
Source: SEC/Edgar
March 18, 2010
Form NT 10-Q
Source: SEC/Edgar
March 17, 2010
Form 424B3
Source: SEC/Edgar
March 08, 2010
Form EFFECT
Source: SEC/Edgar
March 04, 2010
Form POS AM
Source: SEC/Edgar
February 24, 2010
Form SC 13G/A
Source: SEC/Edgar
February 15, 2010
Form SC 13G/A
Source: SEC/Edgar
February 15, 2010
Form 8-K/A
Source: SEC/Edgar
February 10, 2010
Form 8-K
Source: SEC/Edgar
February 04, 2010
Form NT 10-K
Source: SEC/Edgar
January 31, 2010
Form 424B3
Source: SEC/Edgar
January 11, 2010
Form 8-K
Source: SEC/Edgar
January 10, 2010
Form SC 13G
Source: SEC/Edgar
January 10, 2010
Form 424B3
Source: SEC/Edgar
December 15, 2009
Form 8-K
Source: SEC/Edgar
December 14, 2009
Form 424B3
Source: SEC/Edgar
November 08, 2009
Form S-1/A
Source: SEC/Edgar
November 05, 2009
Form EFFECT
Source: SEC/Edgar
November 05, 2009
Form 8-K
Source: SEC/Edgar
November 04, 2009
Form 8-K
Source: SEC/Edgar
November 02, 2009
Form 8-K
Source: SEC/Edgar
October 25, 2009
Form S-1
Source: SEC/Edgar
October 21, 2009
Form D
Source: SEC/Edgar
October 21, 2009
Form D
Source: SEC/Edgar
October 04, 2009
Form D
Source: SEC/Edgar
September 30, 2009
Form 8-K
Source: SEC/Edgar
September 24, 2009
Form NT 10-Q
Source: SEC/Edgar
September 13, 2009
Form 8-K
Source: SEC/Edgar
August 03, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.